HRK and myelodysplastic syndrome: Notably, BH3 profiling revealed an increase in HRK-mediated cytochrome c release, indicative of BCL-xL dependence, in MDS-LGF, Kasumi-1, and EOL-1 cells following treatment with ven alone and aza/ven.